Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (NCT04886284)
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)
🩺 Plain-English Summary (8th-Grade Level)
There is a variety of in vitro, in vivo (animal model), and human case series data which suggests that the addition of ertapenem to cefazolin could improve outcomes in methicillin-susceptible S. aureus bacteremia. No randomized controlled trial has been performed. This study is an approved sub-study of The Staphylococcus aureus Network Adaptive Platform (SNAP) trial (NCT05137119)
Who can join: Review the eligibility criteria below.
Location: Foothills Medical Centre — Calgary, Alberta
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Foothills Medical Centre — Calgary, Alberta
- Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital) — Hamilton, Ontario
- Niagara Health - St. Catharines site — Saint Catharines, Ontario
- Hospital de la Cité de la Sante — Laval, Quebec
- Jewish General Hospital — Montreal, Quebec
- McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital) — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (514) 934-1934
Email: lina.petrella@muhc.mcgill.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Staphylococcus Aureus Bacteremia
- Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia — Melbourne, Victoria
- Staphylococcus Aureus Network Adaptive Platform Trial — Houston, Texas
- Evaluating Simplified Layered Consent for Clinical Trials — Calgary, Alberta
- Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia — Brighton, Colorado
Explore by condition: All Staphylococcus Aureus Bacteremia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.